Hot Pursuit     12-Feb-24
Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
Zydus Lifesciences Ltd is quoting at Rs 861.45, up 7.01% on the day as on 12:49 IST on the NSE. The stock is up 82.72% in last one year as compared to a 21.78% gain in NIFTY and a 52.03% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 861.45, up 7.01% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.65% on the day, quoting at 21641.95. The Sensex is at 71152.48, down 0.62%. Zydus Lifesciences Ltd has added around 20.17% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 6.45% in last one month and is currently quoting at 18617.1, up 0.18% on the day. The volume in the stock stood at 51.87 lakh shares today, compared to the daily average of 12.72 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 860.4, up 6.65% on the day. Zydus Lifesciences Ltd is up 82.72% in last one year as compared to a 21.78% gain in NIFTY and a 52.03% gain in the Nifty Pharma index.

The PE of the stock is 32.71 based on TTM earnings ending September 23.

Previous News
  Zydus enters into non-exclusive patent licensing agreement with Takeda
 ( Corporate News - 17-Jul-24   15:41 )
  Zydus receives USFDA approval for Valsartan Tablets
 ( Corporate News - 23-Jul-24   15:20 )
  Indices trade with moderate losses; PSU bank shares decline
 ( Market Commentary - Mid-Session 23-Jul-24   14:31 )
  Indices trade higher; consumer durable shares rally
 ( Market Commentary - Mid-Session 22-Apr-24   13:37 )
  Zydus' transdermal patch manufacturing facility completes USFDA inspection
 ( Corporate News - 01-Oct-24   12:26 )
  Zydus enters into licensing and supply agreement with MSN Laboaratories
 ( Corporate News - 17-May-24   09:07 )
  Zydus Life’s Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 01-Oct-24   12:13 )
  Sentynl receives marketing authorisation for NULIBRY® from UK MHRA
 ( Corporate News - 20-Apr-24   17:21 )
  Zydus Lifesciences receives USFDA approval for Dapsone Gel 7.5%
 ( Corporate News - 09-May-24   12:36 )
  Zydus Lifesciences declare Quarterly Result
 ( Corporate News - 09-May-24   13:52 )
  Zydus Life gains after receiving USFDA nod for Chlorpromazine Hydrochloride Injection
 ( Hot Pursuit - 14-Mar-24   13:05 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top